Aspen Aerogels (NYSE:ASPN) Trading Down 4.3%

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price traded down 4.3% during mid-day trading on Friday . The stock traded as low as $27.50 and last traded at $27.53. 267,211 shares were traded during trading, a decline of 79% from the average session volume of 1,299,470 shares. The stock had previously closed at $28.76.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Benchmark reaffirmed a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a research note on Thursday, August 8th. B. Riley raised shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, June 25th. Barclays assumed coverage on shares of Aspen Aerogels in a research note on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price target on the stock. Piper Sandler raised their price target on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 29th. Finally, TD Cowen increased their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.70.

Aspen Aerogels Price Performance

The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of -65.36 and a beta of 2.16. The business’s 50-day moving average price is $24.90 and its two-hundred day moving average price is $23.13.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. The firm had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm’s revenue was up 144.4% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.22) earnings per share. On average, research analysts forecast that Aspen Aerogels, Inc. will post 0.21 EPS for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 4.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently modified their holdings of ASPN. Banque Cantonale Vaudoise raised its stake in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in Aspen Aerogels in the second quarter worth about $84,000. nVerses Capital LLC bought a new stake in Aspen Aerogels in the second quarter worth about $95,000. Point72 DIFC Ltd bought a new stake in Aspen Aerogels in the second quarter worth about $121,000. Finally, Public Employees Retirement Association of Colorado bought a new stake in Aspen Aerogels in the second quarter worth about $145,000. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.